PHIO
Phio Pharmaceuticals CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$13.48M
P/E Ratio
—
EPS
$-1.48
Beta
0.84
52W High
$3.48
52W Low
$0.81
50-Day MA
$1.21
200-Day MA
$1.58
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.57
PEG Ratio
—
About Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.62M |
| EBITDA | $-9.22M |
| Operating Margin | 0.00% |
| Return on Equity | -70.00% |
| Return on Assets | -42.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.73 |
| Price-to-Book | 0.66 |
| Price-to-Sales (TTM) | 54.15 |
| EV/Revenue | 233.28 |
| EV/EBITDA | 0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.62M |
| Float | $11.55M |
| % Insiders | 6.00% |
| % Institutions | 8.13% |
Historical Volatility
HV 10-Day
45.60%
HV 20-Day
48.40%
HV 30-Day
48.72%
HV 60-Day
118.54%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026